Oral Cdk inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oral Cdk inhibitor, covering 2014-09-04 to 2014-09-04. Get the full timeline:
Most recent: Clinical Trial Update: Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation [Phase 1]